The report extensively covers the bioactive wound dressing market segmentation by type (moist wound care, active wound care, and antimicrobial care) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). Request Free Sample Report.
Bioactive Wound Dressing Market Vendors
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.
- 3M Co.
- Axio Biosolutions Pvt Ltd
- B. Braun SE
- Coloplast AS
- ConvaTec Group Plc
- Covalon Technologies Ltd.
- DermaRite Industries LLC
- ETS Wound Care LLC
- Hollister Inc.
- Integra Lifesciences Holdings Corp.
- Johnson and Johnson
- Mediterra
- Medtronic Plc
Product Insights and News
- integralife.com: This business sells a product called Integra Wound Matrix which is made of a porous matrix made of cross-linked bovine tendon collagen and glycosaminoglycan.
- Hollister.com - This company sells a variety of bioactive wound dressings, including CalciCare Calcium Alginate Dressing, CalciCare Calcium Alginate Dressing Silver, Hollister Incorporated Restore foam, Hydrocolloid Dressing Sterile, and Hydrocolloid Dressing with Foam Backing.
- etswoundcare.com - This business sells MIRRAGEN, a bioactive product made of glass fibres and borate that is bioabsorbable.
Find additional highlights on the growth strategies adopted by vendors and their product offerings, Buy Sample Report.
Bioactive Wound Dressing Market Geographical Landscape
North America will account for 36% of the market's growth over the forecasted timeframe. The bioactive wound dressing market in North America is mostly centered in the US. The market in this region will expand more slowly than markets in other regions. Over the course of the projection period, the expansion of the North American market for bioactive wound dressings will be supported by the opening of new urgent care centres.
Bioactive Wound Dressing Market
Segmentation
The market share growth for bioactive wound dressings in the moist wound care sector would be high. The largest source of income for the worldwide bioactive wound dressing market is the moist wound dressings segment. This is because of its many benefits, which include promoting quick wound healing, offering improved autolytic debridement, promoting collagen synthesis, and minimizing scarring and pain associated with wounds.
Additionally, a lot of end-users are choosing moist wound dressings more frequently because they keep the area surrounding the wound site moist, assure oxygen flow, eliminate dead tissues, offer protection from external infection, are affordable, and are simple to apply. Download a free sample report
Related Reports:
Medical Cyclotron Market by Product and Geography - Forecast and Analysis 2022-2026: The medical cyclotron market share is expected to increase by USD 64.27 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.8%.
Laboratory Bottle-top Dispenser Market by End-user and Geography - Forecast and Analysis 2022-2026: The laboratory bottle-top dispenser market share is expected to increase by USD 153.1 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.44%.
Bioactive Wound Dressing Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.63% |
Market growth 2022-2026 |
$ 1.17 billion |
Market structure |
Fragmented |
YoY growth (%) |
5.06 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 36% |
Key consumer countries |
US, Germany, France, UK, and Japan |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
3M Co., Axio Biosolutions Pvt Ltd, B. Braun SE, Coloplast AS, ConvaTec Group Plc, Covalon Technologies Ltd., DermaRite Industries LLC, ETS Wound Care LLC, Hollister Inc., Integra Lifesciences Holdings Corp., Johnson and Johnson, Mediterra, Medtronic Plc, MiMedx Group Inc., Molnlycke Health Care AB, Organogenesis Inc., Paul Hartmann AG, Smith and Nephew plc, and UEG Medical |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse for Technavio "Health Care" Research Reports
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Moist wound care - Market size and forecast 2021-2026
- Exhibit 28: Chart on Moist wound care - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Moist wound care - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Moist wound care - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Moist wound care - Year-over-year growth 2021-2026 (%)
- 5.4 Active wound care - Market size and forecast 2021-2026
- Exhibit 32: Chart on Active wound care - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Active wound care - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Active wound care - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Active wound care - Year-over-year growth 2021-2026 (%)
- 5.5 Antimicrobial care - Market size and forecast 2021-2026
- Exhibit 36: Chart on Antimicrobial care - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Antimicrobial care - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Antimicrobial care - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Antimicrobial care - Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by Type
- Exhibit 40: Market opportunity by Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 France - Market size and forecast 2021-2026
- Exhibit 70: Chart on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on France - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on France - Year-over-year growth 2021-2026 (%)
- 7.10 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.11 Japan - Market size and forecast 2021-2026
- Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 3M Co.
- Exhibit 89: 3M Co. - Overview
- Exhibit 90: 3M Co. - Business segments
- Exhibit 91: 3M Co. - Key news
- Exhibit 92: 3M Co. - Key offerings
- Exhibit 93: 3M Co. - Segment focus
- 10.4 B. Braun SE
- Exhibit 94: B. Braun SE - Overview
- Exhibit 95: B. Braun SE - Business segments
- Exhibit 96: B. Braun SE - Key news
- Exhibit 97: B. Braun SE - Key offerings
- Exhibit 98: B. Braun SE - Segment focus
- 10.5 Coloplast AS
- Exhibit 99: Coloplast AS - Overview
- Exhibit 100: Coloplast AS - Business segments
- Exhibit 101: Coloplast AS - Key news
- Exhibit 102: Coloplast AS - Key offerings
- Exhibit 103: Coloplast AS - Segment focus
- 10.6 ConvaTec Group Plc
- Exhibit 104: ConvaTec Group Plc - Overview
- Exhibit 105: ConvaTec Group Plc - Product / Service
- Exhibit 106: ConvaTec Group Plc - Key news
- Exhibit 107: ConvaTec Group Plc - Key offerings
- 10.7 Covalon Technologies Ltd.
- Exhibit 108: Covalon Technologies Ltd. - Overview
- Exhibit 109: Covalon Technologies Ltd. - Business segments
- Exhibit 110: Covalon Technologies Ltd. - Key offerings
- Exhibit 111: Covalon Technologies Ltd. - Segment focus
- 10.8 DermaRite Industries LLC
- Exhibit 112: DermaRite Industries LLC - Overview
- Exhibit 113: DermaRite Industries LLC - Product / Service
- Exhibit 114: DermaRite Industries LLC - Key offerings
- 10.9 ETS Wound Care LLC
- Exhibit 115: ETS Wound Care LLC - Overview
- Exhibit 116: ETS Wound Care LLC - Product / Service
- Exhibit 117: ETS Wound Care LLC - Key offerings
- 10.10 Hollister Inc.
- Exhibit 118: Hollister Inc. - Overview
- Exhibit 119: Hollister Inc. - Product / Service
- Exhibit 120: Hollister Inc. - Key offerings
- 10.11 Integra Lifesciences Holdings Corp.
- Exhibit 121: Integra Lifesciences Holdings Corp. - Overview
- Exhibit 122: Integra Lifesciences Holdings Corp. - Business segments
- Exhibit 123: Integra Lifesciences Holdings Corp. - Key news
- Exhibit 124: Integra Lifesciences Holdings Corp. - Key offerings
- Exhibit 125: Integra Lifesciences Holdings Corp. - Segment focus
- 10.12 Paul Hartmann AG
- Exhibit 126: Paul Hartmann AG - Overview
- Exhibit 127: Paul Hartmann AG - Business segments
- Exhibit 128: Paul Hartmann AG - Key offerings
- Exhibit 129: Paul Hartmann AG - Segment focus
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 130: Inclusions checklist
- Exhibit 131: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 132: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 133: Research methodology
- Exhibit 134: Validation techniques employed for market sizing
- Exhibit 135: Information sources
- 11.5 List of abbreviations
- Exhibit 136: List of abbreviations
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article